Takeaway
- Letrozole in combination with abemaciclib is safe and shows durable response in women with recurrent estrogen receptor-positive endometrioid endometrial cancer, including those who had previously received hormonal therapy.
Why this matters
- These results suggest that letrozole-abemaciclib is not cross-resistant with other hormonal approaches and may represent a viable salvage endocrine...